Condition
Congenital Dysplasia of the Hip
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Terminated2
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04117685Recruiting
Global Hip Dysplasia Registry
NCT04348968Terminated
Maxera Large Cups - Canada
NCT02503891Not ApplicableUnknown
AL-2 MP-1 (Polyimide) Acetabular Liner
NCT01422564Phase 4Terminated
Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem
Showing all 4 trials